Physician

Brian John Ball, M.D.

According to 2025 Medicare claims, Brian Ball, M.D. (NPI: 1356754683) practices hematology in the Los Angeles-Long Beach-Glendale, CA market, with the plurality of this provider's patient population coming from Los Angeles, CA. This provider's primary affiliated billing organization is CITY OF HOPE MEDICAL FOUNDATION (NPI: 1871886366; TIN: 274803222) and primary practice location at 91010-3012. Ball is affiliated with the Collaborative ACO 30, LLC (ACO ID: A5483), participating under the MSSP model.

Ball's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 144 traditional Medicare patients, billed 938 HCPCS/CPT codes, and received $74,955 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 503 prescription claims across 47 beneficiaries totaling $1,703,892 in drug costs, led by Onureg (Azacitidine). 2017 DME data shows 11 claims. Open Payments data shows 9 records totaling $6,758. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have risen steadily, from $18,029 to $1,703,892. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	37	278	$23,354
2021	102	760	$71,346
2022	103	663	$59,319
2023	147	798	$78,600
2024	144	938	$74,955

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	47	200	$18,029
2016	95	495	$67,511
2017	64	263	$24,483
2018	33	48	$10,726
2019	12	25	$29,206
2020	N/R	41	$28,978
2021	19	141	$116,086
2022	23	205	$672,872
2023	40	356	$796,693
2024	47	503	$1,703,892

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	15	$222
2017	N/R	11	$102
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	32	34	$144
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	32	151	$119
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	34	185	$101
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	81	257	$82
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	72	224	$14

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Onureg	Azacitidine	25	700	$622,680
Idhifa	Enasidenib Mesylate	17	510	$529,497
Jakafi	Ruxolitinib Phosphate	13	390	$184,408
Cresemba	Isavuconazonium Sulfate	13	360	$79,091
Posaconazole	Posaconazole	16	443	$26,223

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	9	$6,758	E.R. Squibb & Sons, L.L.C.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Brian John Ball, M.D.?

Tedicare shows public-source Medicare data for Brian John Ball, M.D. (NPI 1356754683), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Brian John Ball, M.D. have ACO affiliation data?

Brian John Ball, M.D. is shown with ACO affiliation data for Collaborative ACO 30, LLC (MSSP, ACO ID A5483).

What billing organization is linked to Brian John Ball, M.D.?

Brian John Ball, M.D. is linked to CITY OF HOPE MEDICAL FOUNDATION (billing NPI 1871886366) in the available physician profile data.

Does Brian John Ball, M.D. have Open Payments data?

Brian John Ball, M.D. has 9 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.